Oblon is headquartered within steps of the United States Patent and Trademark Office (USPTO), and has an affiliate office in Tokyo, Japan. Oblon is…
Oblon | USA | 16 May 2023
The Patent Trial and Appeals Board denied U.S. Well Services, LLC’s (the Patent Owner) Motion to Amend the claims of U.S. Patent No. 10,254,732 B2…
Oblon | USA | 15 May 2023
Today the Supreme Court denied cert in GSK v. Teva in which the Solicitor General filed a brief in support of granting cert. The Solicitor argued…
Oblon | USA | 12 May 2023
On April 28 the Supreme Court heard oral arguments on Amgen’s petition of the Federal Circuit’s decision affirming the district court’s decision on…
Oblon | USA | 11 May 2023
On May 2, 2023, the Patent Trial and Appeal Board (PTAB) reversed the Examiner’s rejection of a claim directed to a method of creating an immobilized…
Oblon | USA | 11 May 2023
In the April 29, 2023 article, the Yomiuri Shimbun reported that a group of creative artists met with government official to discuss legal…
Oblon | USA | 20 Apr 2023
The USPTO today announced Advance Notice of Proposed Rulemaking for PTAB reforms regarding IPRs/PGRs. The proposal related to five areas: Key Area 1:…
Oblon | USA | 10 Apr 2023
On March 15, 2023, the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) issued an opinion in the appeal…
Oblon | USA | 7 Apr 2023
The Regents of the University of Minnesota (“Minnesota”) appealed from a final decision of the U.S. PTO Patent Trial and Appeal Board (“the Board”)…
Oblon | USA | 4 Apr 2023
Minerva Surgical, Inc. sued Hologic, Inc. and Cytyc Surgical Products, LLC in the District of Delaware for infringement of U.S. Patent No. 9,186,208…
Oblon | USA | 3 Apr 2023
In Bausch Health Ireland v. Mylan Pharms. N.D. WV., 1:22CV20 Bausch moved for judgment of infringement on the pleadings under Rule 12(c) to prevent…